The Parkinson's disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration/Experiment 4/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/22

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Supplementary Table 5

Description: Differential abundance of taxa between the drug-amendment experiments(ENT-High, ENT-Low, LOX-High and LOX-Low) after 24hrs of incubation.

Abundance in Group 1: decreased abundance in Loxapine Succinate High Concentration(LOX-High) after 24 hrs of incubation

NCBI	Quality Control	Links
Bacteroides
Bifidobacterium
Candidatus Gastranaerophilales
Clostridium
Flavonifractor
Paraprevotella
Thomasclavelia
unclassified Lachnospiraceae
uncultured Oscillospiraceae bacterium
UCG-010_unclassifiedUCG-010_unclassified
Unclassified Clostridia UCG-014Unclassified Clostridia UCG-014
Prevotella_9Prevotella_9
uncultured_unclassifieduncultured_unclassified

Revision editor(s): KateRasheed